DexCom Inc (DXCM)

DXCM (NASDAQ:Health Services) EQUITY
neg -0.76
Today's Range: 74.79 - 75.98 | DXCM Avg Daily Volume: 1,187,500
Last Update: 08/23/17 - 1:47 PM EDT
Volume: 429,123
YTD Performance: 27.15%
Open: $75.31
Previous Close: $75.91
52 Week Range: $47.92 - $103.29
Oustanding Shares: 86,560,946
Market Cap: 6,324,142,715
6-Month Chart
TheStreet Ratings Grade for DXCM
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 13 12 12 13
Moderate Buy 1 1 1 1
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.41 1.44 1.44 1.41
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -97.41
Price Earnings Comparisons:
DXCM Sector Avg. S&P 500
-97.41 0.00 35.60
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
10.25% -16.18% 72.21%
Revenue 42.60 2.60 0.52
Net Income 0.00 1.20 0.00
EPS 0.00 0.90 0.00
Earnings for DXCM:
Revenue 0.57B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $-0.14 $0.05 $-0.73 $-0.22
Number of Analysts 11 11 9 11
High Estimate $-0.09 $0.12 $-0.61 $0.07
Low Estimate $-0.21 $-0.09 $-0.86 $-0.62
Prior Year $-0.22 $-0.09 $-0.78 $-0.73
Growth Rate (Year over Year) 35.95% 152.53% 6.27% 69.66%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
After a slump early last year, the smartwatch's sales have been rebounding. New features unveiled at Apple's WWDC conference could aid its momentum later this year.
Old-line momentum favorites fare well.
These companies show signs of a change of direction.
The medical device company has been trading sideways for a long time and is likely to continue in the manner.
Jan 03, 2017 | 7:39 AM EST
DXCM was downgraded from Overweight to Equal-weight, Morgan Stanley said. $66 price target. Libre risk is not yet factored into the sto...
Dec 19, 2016 | 6:58 AM EST
DXCM was upgraded from Perform to Outperform, Oppenheimer said. $84 price target. Company is focused on big, long-term opportunities.
Oct 31, 2016 | 8:13 AM EDT
DXCM was upgraded from Neutral to Buy, BTIG said. $92 price target. Stock has pulled back to an attractive level and fundamentals have ...
But several airline and retail stocks are proving highly volatile.
Results on conference picks are split as hedge fund industry contends with criticism.
David Einhorn, Jim Chanos presentations close out 2106's Sohn Investment Conference.

Columnist Conversations

We will take off some more risk, bank some winners SOLD PG OCT 90 CALL AT 3.3 (in at 2.90) ...
After a very calm and sedate period of volatility which saw the VIX fall not only to all time lows but had a r...
today is a good day to lighten the load and take some positions off the table. SOLD WB OCT 85 CALL AT 11 (i...
I reached out last week to my close friend Ken Shreve, who is a prominent writer for the IBD.  I asked Ke...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.